Page last updated: 2024-12-08

n(4)-aminocytosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID197023
SCHEMBL ID3133642
MeSH IDM0084519

Synonyms (34)

Synonym
AC-5461
n(sup 4)-aminocytosine
2,4(1h,3h)-pyrimidinedione, 4-hydrazone
2(1h)-pyrimidinone, 4-hydrazino-
n(4)-aminocytosine
4-hydrazino-2(1h)pyrimidinone
2-hydroxy-4-hydrazinopyrimidine
4-hydrazinylpyrimidin-2-ol
3310-41-6
4-hydrazino-1h-pyrimidin-2-one
AKOS006375174
A5913
6-hydrazinyl-1h-pyrimidin-2-one
4-hydrazino-pyrimidin-2-ol
FT-0601214
S10644
AKOS015855216
AKOS015892325
SCHEMBL3133642
2-hydroxy-4-hydrazino-pyrimidine
mfcd01749722
J-509629
DTXSID10186768
4-hydrazinyl-1,2-dihydropyrimidin-2-one
GS-6556
4-hydrazino-1h-pyrimidin-2-one, aldrichcpr
6-hydrazinopyrimidin-2(1h)-one
CS-W013501
n4-aminocytosine
uracil-4-hydrazone
AMY3941
H10062
SB56296
SY034349
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]